Dr. Chang Lee has unique experience working as an FDA medical reviewer, in CROs, and in pharmaceutical-biotech industries for overall regulatory and clinical strategies in new drug development. He has remained on top of the new paradigm and best industry practices for product development and risk management as well as working global regulatory authorities. Dr. Lee is US board-certified in Clinical Pathology, holds medical licenses, and has held executive level positions in pharmaceutical companies.